There is only one new AI named Indifilin in this report…that’s what I was mentioning ( one molecule in last 30 years)…rest are just code names. Looking at their past success ratio, I don’t think they would succeed in bringing 2nd or 3rd new AI , at least in next 10 years.
And ,also humbly speaking, I would not like to be discuss further about this company. For me it is cyclical generic company where parent is struggling and has a bad track record of last 1-2 decades. Hence would like to stay away as don’t want to waste more time on this.
| Subscribe To Our Free Newsletter |
